Status: Recruiting
Study on Safety and Performance of AdvanCore Bone Void Filler
The objective of this study is to evaluate the safety and performance of AdvanCore implantable bone graft through a 12-month follow-up period in a prospective, parallel-group design, non-controlled, open label, multi-center and real-world setting study. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.
Participants needed: 190
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Artur Salgado SAUpdated: May 31, 2025Locations: 4
Eligibility criteria
Adult subjects ≥ 18 years old, male or female. [+4]
Subjects with any AdvanCore contraindication for implantation or use. [+4]